Unjha Formulations Intrinsic Value
Unjha Formulations intrinsic value. Unjha Formulations (UNJHAFOR) median intrinsic value is ₹18.57 from 9 valuation models (range ₹13–₹60), vs current price ₹32.00 — -42.0% downside (Trading Above Calculated Value), margin of safety -72.3%. Read UNJHAFOR dividend growth for the complete payout history and dividend yield track record.
UNJHAFOR Valuation Methods Summary — DCF, Graham Number & P/E
Unjha Formulations intrinsic value across 9 models vs current price ₹32.00 — upside/downside and value range per method. For current market price and key ratios, visit UNJHAFOR share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹24.20 | ₹19.36 - ₹29.04 | -24.4% | EPS: ₹1.10, Sector P/E: 22x |
| Book Value Method | asset | ₹16.00 | ₹14.40 - ₹17.60 | -50.0% | Book Value/Share: ₹8.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹60.00 | ₹54.00 - ₹66.00 | +87.5% | Revenue/Share: ₹30.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹20.00 | ₹18.00 - ₹22.00 | -37.5% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹18.57 | ₹14.86 - ₹22.28 | -42.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹13.16 | ₹11.84 - ₹14.48 | -58.9% | EPS Growth: 15.0%, Fair P/E: 12.0x |
| Growth Adjusted P/E | growth | ₹16.80 | ₹15.12 - ₹18.48 | -47.5% | Revenue Growth: 3.6%, Adj P/E: 15.3x |
| ROE Based Valuation | profitability | ₹32.00 | ₹28.80 - ₹35.20 | 0.0% | ROE: 25.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹14.07 | ₹12.66 - ₹15.48 | -56.0% | EPS: ₹1.10, BVPS: ₹8.00 |
UNJHAFOR Intrinsic Value vs Market Price — All Valuation Models
Unjha Formulations fair value range ₹13–₹60 vs current market price ₹32.00 across 9 valuation models. Compare with UNJHAFOR fair price to assess whether the stock is under or overvalued.
UNJHAFOR Intrinsic Value Analysis — Undervalued or Overvalued?
Unjha Formulations median intrinsic value ₹18.57, current price ₹32.00 — Trading Above Calculated Value by 42.0%, margin of safety -72.3%.
What is the intrinsic value of UNJHAFOR?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Unjha Formulations (UNJHAFOR) is ₹18.57 (median value). With the current market price of ₹32.00, this represents a -42.0% variance from our estimated fair value.
The valuation range spans from ₹13.16 to ₹60.00, indicating ₹13.16 - ₹60.00.
Is UNJHAFOR undervalued or overvalued?
Based on our multi-method analysis, Unjha Formulations (UNJHAFOR) appears to be trading above calculated value by approximately 42.0%.
UNJHAFOR Financial Health — Key Ratios vs Industry Benchmarks
Unjha Formulations financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 25.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.50x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
UNJHAFOR Cash Flow Quality — Operating & Free Cash Flow
Unjha Formulations operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |